CAMBRIDGE, Mass., Jan. 4, 2021 /PRNewswire/ -- Akebia
Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company
with the purpose to better the lives of people impacted by kidney
disease, today announced that John P.
Butler, President and Chief Executive Officer, will present
virtually at the 39th Annual J.P. Morgan Healthcare
Conference on Wednesday, January 13,
at 2:50 p.m. EST.
A live webcast and replay of Akebia's presentation and
associated Q&A will be available on the Investors section of
the Company's website at https://ir.akebia.com.
About Akebia Therapeutics
Akebia Therapeutics, Inc. is a fully integrated
biopharmaceutical company with the purpose to better the lives of
people impacted by kidney disease. The Company was founded in 2007
and is headquartered in Cambridge,
Massachusetts. For more information, please visit our
website at www.akebia.com, which does not form a part of this
release.
Akebia Therapeutics Contact
Kristen K. Sheppard, Esq.
ir@akebia.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/akebia-therapeutics-to-present-at-39th-annual-jp-morgan-healthcare-conference-301199899.html
SOURCE Akebia Therapeutics